Remission of rheumatoid arthritis is difficult to achieve and sustain. Researchers examined the differences in outcome between remission and low disease activity, and their effect of function, quality of...
Remission of rheumatoid arthritis is difficult to achieve and sustain. Researchers examined the differences in outcome between remission and low disease activity, and their effect of function, quality of...
An analysis of electronic health records from 56 million adults taking at least one prescription for a TNF-blocking agent or methotrexate showed promise for reducing the risk of Alzheimer disease. Find out...
In a new study, researchers assessed the effects of a 3-month, RA-tailored exercise program among patients with rheumatoid arthritis. Read more about the programs and results here.
Previous research has suggested a positive association between smoking and rheumatoid arthritis risk. Now, authors of a new study sought to determine the relationship’s causality. Read about their findings...
The authors of a new study investigated the relationship between glucocorticoid use, type 2 diabetes mellitus, and mortality among more than 9000 patients with incident rheumatoid arthritis. Here is what...
Can an ultrasonography-guided treat-to-target approach reduce inflammation assessed by MRI or joint damage compared with a conventional treat-to-target approach during follow-up of early rheumatoid...
Although patients with rheumatoid arthritis are at an increased risk for seasonal influenza, their vaccine immunogenicity is reduced. The authors of a new study analyzed whether this patient population...
Researchers evaluated the effect of upadacitinib on patient-reported outcomes in patients with rheumatoid arthritis who had an inadequate response to conventional synthetic DMARDs.
Researchers evaluated the effect of upadacitinib on patient-reported outcomes in patients with rheumatoid arthritis who had an inadequate response to conventional synthetic DMARDs.
